Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O (2015)
BMC Public Health 15: 533.

Download
OA
Journal Article | Published | English
Author
; ; ; ; ;
Abstract
BACKGROUND: A systematic review was conducted to assess the cost-effectiveness of routine varicella and herpes zoster (HZ) vaccination in high-income countries estimated by modelling studies.; METHODS: A PubMed search was performed to identify relevant studies published before October 2013. Studies were included in the review if they (i) evaluated the cost-effectiveness of routine childhood or adolescent varicella vaccination and/or HZ vaccination targeting the elderly, and if they (ii) reported results for high-income countries.; RESULTS: A total of 38 model-based studies were identified that fulfilled the inclusion criteria. Routine childhood or adolescent varicella vaccination was cost-effective or cost-saving from a payer perspective and always cost-saving from a societal perspective when ignoring its potential impact on HZ incidence due to reduced or absent exogenous boosting. The inclusion of the potential impact of childhood varicella vaccination on HZ led to net quality-adjusted life-year (QALY) losses or incremental cost-effectiveness ratios exceeding commonly accepted thresholds. Additional HZ vaccination could partially mitigate this effect. Studies focusing only on the evaluation of HZ vaccination reported a wide range of results depending on the selected target age-group and the vaccine price, but most found HZ vaccination to be a cost-effective or marginally cost-effective intervention. Cost-effectiveness of HZ vaccination was strongly dependent on the age at vaccination, the price of the vaccine, the assumed duration of protection and the applied cost per QALY threshold.; CONCLUSIONS: While HZ vaccination is mostly considered cost-effective, cost-effectiveness of varicella vaccination primarily depends on the in- or exclusion of exogenous boosting in the model. As a consequence, clarification on the role of exogenous boosting is crucial for decision-making regarding varicella vaccination.
Publishing Year
ISSN
Financial disclosure
Article Processing Charge funded by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.
PUB-ID

Cite this

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 2015;15: 533.
Damm, O., Ultsch, B., Horn, J., Mikolajczyk, R. T., Greiner, W., & Wichmann, O. (2015). Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health, 15: 533.
Damm, O., Ultsch, B., Horn, J., Mikolajczyk, R. T., Greiner, W., and Wichmann, O. (2015). Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health 15:533.
Damm, O., et al., 2015. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health, 15: 533.
O. Damm, et al., “Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.”, BMC Public Health, vol. 15, 2015, : 533.
Damm, O., Ultsch, B., Horn, J., Mikolajczyk, R.T., Greiner, W., Wichmann, O.: Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 15, : 533 (2015).
Damm, Oliver, Ultsch, Bernhard, Horn, Johannes, Mikolajczyk, Rafael T, Greiner, Wolfgang, and Wichmann, Ole. “Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.”. BMC Public Health 15 (2015): 533.
Main File(s)
Access Level
OA Open Access
Last Uploaded
2016-02-26T06:54:36Z

This data publication is cited in the following publications:
This publication cites the following data publications:

2 Citations in Europe PMC

Data provided by Europe PubMed Central.

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B, Damm O, Beutels P, Bilcke J, Bruggenjurgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O., Pharmacoeconomics 34(3), 2016
PMID: 26477039
The 'Dynamic' Marriage Between Varicella and Zoster.
de Boer PT, Wilschut JC, Postma MJ., EBioMedicine 2(10), 2015
PMID: 26629519

72 References

Data provided by Europe PubMed Central.

Economic evaluation of varicella vaccination in Swiss children and adolescents.
Banz K, Iseli A, Aebi C, Brunner M, Schmutz AM, Heininger U., Hum Vaccin 5(12), 2009
PMID: 19829048
Varicella vaccination in Italy : an economic evaluation of different scenarios.
Coudeville L, Brunot A, Giaquinto C, Lucioni C, Dervaux B., Pharmacoeconomics 22(13), 2004
PMID: 15329030
The economic value of childhood varicella vaccination in France and Germany.
Coudeville L, Brunot A, Szucs TD, Dervaux B., Value Health 8(3), 2005
PMID: 15877593
A cost benefit analysis of routine varicella vaccination in Spain.
Diez Domingo J, Ridao M, Latour J, Ballester A, Morant A., Vaccine 17(11-12), 1999
PMID: 10195765
Instituting a routine varicella vaccination program in Canada: an economic evaluation.
Getsios D, Caro JJ, Caro G, De Wals P, Law BJ, Robert Y, Lance JM., Pediatr. Infect. Dis. J. 21(6), 2002
PMID: 12182379
Childhood vaccination against chickenpox: an analysis of benefits and costs.
Huse DM, Meissner HC, Lacey MJ, Oster G., J. Pediatr. 124(6), 1994
PMID: 8201469
Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B., Vaccine 24(47-48), 2006
PMID: 16860909
Cost-effectiveness of a routine varicella vaccination program for US children.
Lieu TA, Cochi SL, Black SB, Halloran ME, Shinefield HR, Holmes SJ, Wharton M, Washington AE., JAMA 271(5), 1994
PMID: 8283587
A benefit-cost analysis of a childhood varicella vaccination programme.
Preblud SR, Orenstein WA, Koplan JP, Bart KJ, Hinman AR., Postgrad Med J 61 Suppl 4(), 1985
PMID: 3939152
The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
Scuffham P, Devlin N, Eberhart-Phillips J, Wilson-Salt R., Soc Sci Med 49(6), 1999
PMID: 10459888
An economic evaluation of varicella vaccination in Italian adolescents.
Thiry N, Beutels P, Tancredi F, Romano L, Zanetti A, Bonanni P, Gabutti G, Van Damme P., Vaccine 22(27-28), 2004
PMID: 15315834
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis.
Bresse X, Annemans L, Preaud E, Bloch K, Duru G, Gauthier A., Expert Rev Pharmacoecon Outcomes Res 13(3), 2013
PMID: 23537397
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.
Brisson M, Pellissier JM, Camden S, Quach C, De Wals P., Hum Vaccin 4(3), 2008
PMID: 18382137
A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.
Moore L, Remy V, Martin M, Beillat M, McGuire A., Cost Eff Resour Alloc 8(), 2010
PMID: 20433704
Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland.
Szucs TD, Kressig RW, Papageorgiou M, Kempf W, Michel JP, Fendl A, Bresse X., Hum Vaccin 7(7), 2011
PMID: 21606685
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.
van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ., Vaccine 27(9), 2009
PMID: 19135492

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 26041469
PubMed | Europe PMC

Search this title in

Google Scholar